Compare

5-Amino-1MQ vs BPC-157

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Last reviewed . By the PeptIQ team.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

5-Amino-1MQ

1726 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 70% · Mixed 12% · Unfavorable overall 18%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Mood
89
Focus
66
Sleep quality
63
Lean mass
85
Joint comfort
133

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Fatigue
185
Nausea
146
Water retention
28
Appetite loss
81
Injection site reaction
133

Self-reported dose per injection

Median bucket: 0.4–0.6 mg · Most common: 0.4–0.6 mg

Reports span 0.05–2 mg

0.05–0.1 mg
2
0.1–0.2 mg
9
0.2–0.4 mg
16
0.4–0.6 mg
23
0.6–1 mg
16
1–2 mg
9

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing50stacking43side effects365-amino-1mq9

How repeat users are trending

Among repeat reporters, 65% said they felt similar to their last entry, 32% more positive, and 20% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 33 days · Based on 380 repeat reporters

BPC-157

2443 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 67% · Mixed 18% · Unfavorable overall 15%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Skin appearance
-158
Appetite control
-32
Energy
-84
Mood
0
Focus
-102

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Headache
-62
GI discomfort
-133
Dizziness
-119
Fatigue
-5
Nausea
-103

Self-reported dose per injection

Median bucket: 0.6–1 mg · Most common: 0.6–1 mg

Reports span 0.05–5 mg

0.05–0.1 mg
4
0.1–0.2 mg
7
0.2–0.4 mg
12
0.4–0.6 mg
22
0.6–1 mg
31
1–2 mg
20
2–3 mg
11
3–5 mg
3

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing47stacking15side effects33bpc-15726

How repeat users are trending

Among repeat reporters, 62% said they felt similar to their last entry, 41% more positive, and 17% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 33 days · Based on 537 repeat reporters

Sources (13)

Published sources linked on the 5-Amino-1MQ and BPC-157 wiki pages.

  1. PubMed

    An NNMT inhibitor activates oxidative metabolism and reduces obesity in mice

    Neelakantan H, Vance V, Wang H, et al. Nat Commun. 2019

    Source
    Wiki study page →
  2. PubMed

    NNMT inhibition in cancer-associated fibroblasts restores antitumour immunity

    Heide J, Bilecz AJ, Patnaik S, et al. Nature. 2025

    Source
    Wiki study page →
  3. PubMed

    Exploring NNMT: from metabolic pathways to therapeutic targets

    Park J, Shin EJ, Kim TH, et al. Archives of pharmacal research. 2024

    Source
    Wiki study page →
  4. PubMed

    Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract

    Sikiric P, Seiwerth S, Rucman R, et al. Curr Pharm Des. 2018

    Source
    Wiki study page →
  5. PubMed

    Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts

    Chang CH, Tsai WC, Lin MS, et al. Molecules. 2019

    Source
    Wiki study page →
  6. PubMed

    BPC 157 and its role in accelerating wound healing

    Vukojevic J, Siroglavic M, Kasnik K, et al. Int J Mol Sci. 2022

    Source
    Wiki study page →
  7. ClinicalTrials.gov

    BPC-157 studies on ClinicalTrials.gov

    ClinicalTrials.gov. Clinical trial registry. 2024

    Source
    Wiki study page →
  8. PubMed

    BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing

    Seiwerth S, Rucman R, Turkovic B, et al. Current pharmaceutical design. 2018

    Source
    Wiki study page →
  9. PubMed

    Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions

    Ilic S, Drmic D, Franjic S, et al. Life sciences. 2011

    Source
    Wiki study page →
  10. PubMed

    Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain

    Lee E, Padgett B. Altern Ther Health Med. 2021

    Source
    Wiki study page →
  11. PubMed

    From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management

    Yuan C, Demers A, Silva-Ortiz V, et al. Int J Mol Sci. 2026

    Source
    Wiki study page →
  12. PubMed

    Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians

    Mayfield CK, Bolia IK, Feingold CL, et al. Am J Sports Med. 2026

    Source
    Wiki study page →
  13. PubMed

    Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

    Rahman OF, Lee SJ, Seeds WA. JAAOS Glob Res Rev. 2026

    Source
    Wiki study page →